āĻšā§āĻŽFOLD âĸ NASDAQ
add
Amicus Therapeutics, Inc.
ā§§ā§Ē.ā§¨ā§Ž$
āĻāĻŖā§āĻāĻž āĻĒāĻ°ā§:(ā§Ļ.ā§¨ā§Ž%)+ā§Ļ.ā§Ļā§Ēā§Ļ
ā§§ā§Ē.ā§Šā§¨$
āĻŦāĻ¨ā§āĻ§ āĻāĻā§: ā§¯ āĻāĻžāĻ¨ā§, ā§Ŧ:ā§Ēā§§:ā§§ā§Ģ PM GMT -ā§Ģ · USD · NASDAQ · āĻĄāĻŋāĻ¸āĻā§āĻ˛ā§āĻŽāĻžāĻ°
āĻ¸ā§āĻāĻāĻŽāĻžāĻ°ā§āĻāĻŋāĻ¨ āĻ¯ā§āĻā§āĻ¤āĻ°āĻžāĻˇā§āĻā§āĻ°-āĻ āĻ¤āĻžāĻ˛āĻŋāĻāĻžāĻā§āĻā§āĻ¤ āĻ¸āĻŋāĻāĻŋāĻāĻ°āĻŋāĻāĻŋ
āĻāĻžāĻ˛ āĻļā§āĻˇ āĻ¯ā§ āĻĻāĻžāĻŽā§ āĻāĻŋāĻ˛
ā§§ā§Ē.ā§¨ā§Ž$
āĻ¸āĻžāĻ°āĻž āĻĻāĻŋāĻ¨ā§āĻ° āĻā§āĻ°ā§āĻĄāĻŋāĻā§ā§ āĻ¸ā§āĻāĻā§āĻ° āĻĻāĻžāĻŽā§āĻ° āĻāĻ āĻž āĻ¨āĻžāĻŽāĻžāĻ° āĻ°ā§āĻā§āĻ
ā§§ā§Ē.ā§¨ā§Ž$ - ā§§ā§Ē.ā§Šā§Ļ$
āĻ¸āĻžāĻ°āĻž āĻŦāĻāĻ°ā§āĻ° āĻ°ā§āĻā§āĻ
ā§Ģ.ā§Ģā§§$ - ā§§ā§Ē.ā§Šā§Ŧ$
āĻŽāĻžāĻ°ā§āĻā§āĻ āĻā§āĻ¯āĻžāĻĒ
ā§Ēā§Ēā§§.ā§Ŧā§¯Â āĻā§ USD
āĻāĻĄāĻŧ āĻāĻ˛āĻŋāĻāĻŽ
ā§§.ā§Ģā§§Â āĻā§
P/E āĻ
āĻ¨ā§āĻĒāĻžāĻ¤
-
āĻ˛āĻā§āĻ¯āĻžāĻāĻļ āĻĒā§āĻ°āĻĻāĻžāĻ¨
-
āĻĒā§āĻ°āĻžāĻāĻŽāĻžāĻ°āĻŋ āĻāĻā§āĻ¸āĻā§āĻā§āĻ
NASDAQ
āĻāĻŦāĻ°ā§ āĻ°ā§ā§āĻā§
āĻĢāĻžāĻāĻ¨āĻžāĻ¨ā§āĻ¸āĻŋā§āĻžāĻ˛ āĻĒāĻžāĻ°āĻĢāĻ°ā§āĻŽā§āĻ¯āĻžāĻ¨ā§āĻ¸
āĻā§ā§āĻ° āĻ¸ā§āĻā§āĻāĻŽā§āĻ¨ā§āĻ
āĻāĻĒāĻžāĻ°ā§āĻāĻ¨
āĻ¨ā§āĻ āĻāĻ¨āĻāĻžāĻŽ
| (USD) | āĻ¸ā§āĻĒ ā§¨ā§Ļā§¨ā§Ģinfo | Y/Y āĻĒāĻ°āĻŋāĻŦāĻ°ā§āĻ¤āĻ¨ |
|---|---|---|
āĻāĻĒāĻžāĻ°ā§āĻāĻ¨ | ā§§ā§Ŧ.ā§¯ā§§Â āĻā§ | ā§§ā§¯.ā§Ēā§Ŧ% |
āĻŦā§āĻ¯āĻŦāĻ¸āĻž āĻāĻžāĻ˛āĻžāĻ¨ā§āĻ° āĻāĻ°āĻ | ā§§ā§§.ā§Ģā§ŠÂ āĻā§ | ā§§ā§§.ā§Ēā§¯% |
āĻ¨ā§āĻ āĻāĻ¨āĻāĻžāĻŽ | ā§§.ā§ā§ŠÂ āĻā§ | ā§Šā§Ģā§.ā§§ā§¯% |
āĻ¨ā§āĻ āĻĒā§āĻ°āĻĢāĻŋāĻ āĻŽāĻžāĻ°ā§āĻāĻŋāĻ¨ | ā§§ā§Ļ.ā§¨ā§Ē | ā§Šā§§ā§Ģ.ā§Ģā§Ž% |
āĻļā§ā§āĻžāĻ° āĻĒā§āĻ°āĻ¤āĻŋ āĻāĻĒāĻžāĻ°ā§āĻāĻ¨ | ā§Ļ.ā§§ā§ | ā§ā§Ļ.ā§Ļā§Ļ% |
EBITDA | ā§Š.ā§Ŧā§§Â āĻā§ | ā§Šā§Ē.ā§Ļā§Ļ% |
āĻĒā§āĻ°āĻ¯ā§āĻā§āĻ¯ āĻā§āĻ¯āĻžāĻā§āĻ¸ā§āĻ° āĻšāĻžāĻ° | ā§Ēā§¯.ā§Ģā§§% | â |
āĻŦā§āĻ¯āĻžāĻ˛ā§āĻ¨ā§āĻ¸ āĻļāĻŋāĻ
āĻŽā§āĻ āĻ¸āĻŽā§āĻĒāĻĻ
āĻŽā§āĻ āĻĻāĻžā§
| (USD) | āĻ¸ā§āĻĒ ā§¨ā§Ļā§¨ā§Ģinfo | Y/Y āĻĒāĻ°āĻŋāĻŦāĻ°ā§āĻ¤āĻ¨ |
|---|---|---|
āĻā§āĻ¯āĻžāĻļ āĻ āĻāĻŽ āĻ¸āĻŽā§ā§āĻ° āĻŦāĻŋāĻ¨āĻŋā§ā§āĻ | ā§¨ā§Ŧ.ā§Šā§ŽÂ āĻā§ | ā§Ģ.ā§Ŧā§Ē% |
āĻŽā§āĻ āĻ¸āĻŽā§āĻĒāĻĻ | ā§Žā§Ŧ.ā§Žā§ŽÂ āĻā§ | ā§§ā§Ļ.ā§Ēā§Ŧ% |
āĻŽā§āĻ āĻĻāĻžā§ | ā§Ŧā§Š.ā§Žā§Ē āĻā§ | ā§Ģ.ā§Ļā§Ē% |
āĻŽā§āĻ āĻāĻā§āĻāĻāĻŋ | ā§¨ā§Š.ā§Ļā§Ē āĻā§ | â |
āĻāĻāĻāĻ¸ā§āĻā§āĻ¯āĻžāĻ¨ā§āĻĄāĻŋāĻ āĻļā§ā§āĻžāĻ° | ā§Šā§Ļ.ā§Žā§Ģ āĻā§ | â |
āĻĒā§āĻ°āĻžāĻāĻ¸ āĻā§ āĻŦā§āĻ āĻ°ā§āĻļāĻŋāĻ | ā§§ā§¯.ā§Ļā§Ē | â |
āĻ¸āĻŽā§āĻĒāĻĻ āĻĨā§āĻā§ āĻā§ | ā§§ā§Ļ.ā§§ā§% | â |
āĻŽā§āĻ˛āĻ§āĻ¨ āĻĨā§āĻā§ āĻā§ | ā§§ā§¨.ā§¯ā§% | â |
āĻā§āĻ¯āĻžāĻļ āĻĢā§āĻ˛ā§
āĻ¨āĻāĻĻā§ āĻŽā§āĻ āĻĒāĻ°āĻŋāĻŦāĻ°ā§āĻ¤āĻ¨
| (USD) | āĻ¸ā§āĻĒ ā§¨ā§Ļā§¨ā§Ģinfo | Y/Y āĻĒāĻ°āĻŋāĻŦāĻ°ā§āĻ¤āĻ¨ |
|---|---|---|
āĻ¨ā§āĻ āĻāĻ¨āĻāĻžāĻŽ | ā§§.ā§ā§ŠÂ āĻā§ | ā§Šā§Ģā§.ā§§ā§¯% |
āĻ
āĻĒāĻžāĻ°ā§āĻļāĻ¨ āĻĨā§āĻā§ āĻĒāĻžāĻā§āĻž āĻā§āĻ¯āĻžāĻļ | ā§Š.ā§Ģā§Â āĻā§ | ā§¨ā§Ģā§Ģ.ā§¨ā§Ē% |
āĻŦāĻŋāĻ¨āĻŋā§ā§āĻ āĻĨā§āĻā§ āĻĒā§āĻ°āĻžāĻĒā§āĻ¤ āĻā§āĻ¯āĻžāĻļ | -ā§§ā§¨.ā§¯ā§¯Â āĻ˛āĻž | -ā§§ā§Ļā§Š.ā§ā§¯% |
āĻĢāĻžāĻāĻ¨ā§āĻ¯āĻžāĻ¨ā§āĻ¸āĻŋāĻ āĻĨā§āĻā§ āĻĒā§āĻ°āĻžāĻĒā§āĻ¤ āĻā§āĻ¯āĻžāĻļ | -ā§§ā§Š.ā§§ā§¯Â āĻ˛āĻž | -ā§§ā§Ļā§.ā§¨ā§Ģ% |
āĻ¨āĻāĻĻā§ āĻŽā§āĻ āĻĒāĻ°āĻŋāĻŦāĻ°ā§āĻ¤āĻ¨ | ā§Š.ā§§ā§ŽÂ āĻā§ | ā§Šā§Ļ.ā§§ā§Ŧ% |
āĻĢā§āĻ°āĻŋ āĻā§āĻ¯āĻžāĻļ āĻĢā§āĻ˛ā§ | ā§Ē.ā§¨ā§Ē āĻā§ | ā§¨ā§Ēā§.ā§§ā§§% |
āĻ¸āĻŽā§āĻĒāĻ°ā§āĻā§
Amicus Therapeutics, Inc. is a public American biopharmaceutical company based in Philadelphia, Pennsylvania. The company went public in 2007 under the Nasdaq trading symbol FOLD. This followed a 2006 planned offering and subsequent withdrawal, which would have established the trading symbol as AMTX Prior to their IPO, Amicus was funded by a variety of venture capital firms including Radius Ventures, Canaan Partners and New Enterprise Associates. Wikipedia
āĻ¸ā§āĻĨāĻžāĻĒāĻŋāĻ¤ āĻšā§ā§āĻā§
ā§Ē āĻĢā§āĻŦ, ā§¨ā§Ļā§Ļā§¨
āĻā§ā§āĻŦāĻ¸āĻžāĻāĻ
āĻāĻ°ā§āĻŽāĻāĻžāĻ°ā§
ā§Ēā§¯ā§¯
